Please login to the form below
15
Revenue 2017Novo Nordisk
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novo Nordisk's 2013 sales performance.
Novo Nordisk enters new research alliance for diabetes and cardiometabolic diseases
Novo Nordisk and the Broad Institute of MIT and Harvard have announced a new research alliance to address ‘critical unmet clinical needs’ in diabetes and cardiometabolic diseases. ... The Novo side of the collaboration is secured through the Novo
Eli Lilly’s Mounjaro receives NICE recommendation to treat type 2 diabetes
Evidence from clinical trials showed that Mounjaro resulted in significant reductions in blood sugar levels and body weight in comparison to Novo Nordisk’s semaglutide injection, insulin therapy or a placebo.
Boehringer and Lilly’s Jardiance granted MHRA approval to treat chronic kidney disease
The deal gives Lilly access to Versanis' lead asset, bimagrumab, a monoclonal antibody currently being assessed in a mid-stage trial as both a monotherapy and in combination with Novo
Novo Nordisk acquires Embark Biotech in deal worth over €470m
Novo Nordisk has announced its acquisition of Embark Biotech in a deal worth over 470m, marking another expansion of the Danish drugmaker’s cardiometabolic disease pipeline. ... We are thrilled to pass on the baton for our lead metabolic programme to
US government announces first ten drugs subject to Medicare pricing negotiations
Boehringer Ingelheim's Jardiance (empagliflozin) and Novo Nordisk's Novolog/Fiasp (insulin aspart).
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Diversity and inclusion in clinical trials: keeping up momentum
- 10 Important Advisor Questions: Placement of Your Product in the Current/Future Treatment Algorithm
- Merck announces partnerships worth $1.3bn with BenevolentAI and Exscientia
- EC approves Menarini Group’s Orserdu for advanced or metastatic breast cancer
- Eli Lilly files US lawsuits over ‘unlawful’ sales of Mounjaro counterfeits
- Takeda announces CHMP recommendation for Adcetris in Hodgkin lymphoma
No results were found
PMHub
EPG Health
REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical education website. Support...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
